ANTI-PD-L1 IMMUNOTOXIN FOR USE IN THERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15563324

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to a combination of an anti-PD-L1 (Programmed Cell Death 1 Ligand 1) with an ‘immunotoxin’ for use in a method for treating a tumor in a patient. Experimental results are provided for a combination of an anti POL 1 antibody with the radioisotope Indium 111.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS3 RUE MICHEL ANGE CEDEX 16 PARIS 75794
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS CEDEX 13 75654
UNIVERSITE D'AIX-MARSEILLE13007 MARSEILLE
INSTITUT JEAN PAOLI & IRENE CALMETTES232 BOULEVARD DE SAINTE MARGUERITE MARSEILLE 13009

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
OLIVE, Daniel Marseille, FR 52 375

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation